AllStripes Announces Rare Disease Research Expansion into the United Kingdom
AllStripes Announces Rare Disease Research Expansion into the United Kingdom AllStripes approved to conduct research with patients residing in England, Scotland, Wales and Northern Ireland AllStripes, a healthcare technology company dedicated to accelerating treatment research for patients with rare diseases, today announced it is expanding its rare disease research efforts into the United Kingdom. This is the company's first major expansion outside of North America AllStripes currently conducts research in the United States and Canada and represents a significant milestone for the rare disea...